world is news

EU may pay over $10 billion for Pfizer, CureVac vaccines

Spread the news

Brussels: The European Union may pay greater than $10 billion to safe lots of of hundreds of thousands of doses of the vaccine candidates being developed by Pfizer-Bio-NTech and CureVac, an EU official concerned within the talks informed Reuters. The bloc has agreed to pay Euro 15.50 ($18.34) per dose for the Covid-19 vaccine candidate being developed by Pfizer and BioNTech, based on the official.

That would imply an general worth of as much as Euro 3.1 billion ($3.7 billion) for 200 million doses, rising to 4.65 Euro billion if one other elective 100 million doses are bought beneath the deal, the official stated. The pricing data confirms the EU is paying much less per dose than the US for an preliminary provide of that vaccine.

The deal contains an insurance coverage for EU nations to get compensation if the businesses divert doses to the US, based on the supply, who requested anonymity because of the sensitivity of the matter. The EU has individually agreed to pay Euro 10 ($11.84) per dose for an preliminary provide of 225 million doses of the vaccine from CureVac, a reduction from the ¤12 the corporate set as the value for the shot.

Spread the news